| ||||||||||||||
|
|
|||||||||||||
Anesthesia & Analgesia, Vol 83, 574-577, Copyright © 1996 by International Anesthesia Research Society
GENERAL ARTICLES |
T Nishiyama, M Aibiki and K Hanaoka
Department of Anesthesiology, Faculty of Medicine, University of Tokyo, Japan.
Although sevoflurane is used in clinical anesthesia, its effects on renal function and inorganic fluoride (F-) kinetics in patients with chronic renal failure (CRF) have not been determined. We investigated F- kinetics and renal tubular function in sevoflurane anesthesia in CRF patients having hemodialysis. Five patients dialyzed and five with normal renal function undergoing parathyroidectomy or thyroidectomy were anesthetized with sevoflurane (1.0%-2.5%) and nitrous oxide in oxygen. Serum and urine levels of F-, blood urea nitrogen (BUN), serum creatinine (Cr), serum and urine beta 2-microglobulin (BMG) levels, and urine N-acetyl-beta-D-glucosaminidase (NAG) level were measured. BUN, Cr, and serum and urine BMG levels were significantly higher in the CRF patients than in the controls. There were no differences in serum F- level, rate of elimination, and area under the curve of serum F- levels between the two groups. However, the CRF patients had a significantly lower level of urine F- than control subjects. These data suggest that the F- kinetics in the CRF patients is different from that in normal renal function subjects. This clinical study with a limited number of patients may facilitate further studies to define the mechanisms of differences in the F- kinetics between normal subjects and CRF patients having hemodialysis after sevoflurane anesthesia.
This article has been cited by other articles:
![]() |
R. G. Craig and J. M. Hunter Recent developments in the perioperative management of adult patients with chronic kidney disease Br. J. Anaesth., September 1, 2008; 101(3): 296 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Higuchi, Y. Adachi, H. Wada, M. Kanno, and T. Satoh The Effects of Low-Flow Sevoflurane and Isoflurane Anesthesia on Renal Function in Patients with Stable Moderate Renal Insufficiency Anesth. Analg., March 1, 2001; 92(3): 650 - 655. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Iyer, R. B. Baggs, and M. W. Anders Nephrotoxicity of the Glutathione and Cysteine S-Conjugates of the Sevoflurane Degradation Product 2-(Fluoromethoxy)-1,1,3,3,3-pentafluoro-1-propene (Compound A) in Male Fischer 344 Rats J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1544 - 1551. [Abstract] [Full Text] |
||||
|